103 related articles for article (PubMed ID: 8424302)
41. Effect of a human urinary protease inhibitor (Ulinastatin) on respiratory function in pediatric patients undergoing cardiopulmonary bypass.
Sugita T; Watarida S; Katsuyama K; Nakajima Y; Yamamoto R; Mori A
J Cardiovasc Surg (Torino); 2002 Aug; 43(4):437-40. PubMed ID: 12124548
[TBL] [Abstract][Full Text] [Related]
42. Effects of methylprednisolone and a biocompatible copolymer circuit on blood activation during cardiopulmonary bypass.
Rubens FD; Nathan H; Labow R; Williams KS; Wozny D; Karsh J; Ruel M; Mesana T
Ann Thorac Surg; 2005 Feb; 79(2):655-65. PubMed ID: 15680854
[TBL] [Abstract][Full Text] [Related]
43. Inflammatory mediators in adults undergoing cardiopulmonary bypass: comparison of centrifugal and roller pumps.
Ashraf S; Butler J; Tian Y; Cowan D; Lintin S; Saunders NR; Watterson KG; Martin PG
Ann Thorac Surg; 1998 Feb; 65(2):480-4. PubMed ID: 9485250
[TBL] [Abstract][Full Text] [Related]
44. Circulating human leucocyte elastase in patients with inflammatory bowel disease.
Adeyemi EO; Neumann S; Chadwick VS; Hodgson HJ; Pepys MB
Gut; 1985 Dec; 26(12):1306-11. PubMed ID: 3853525
[TBL] [Abstract][Full Text] [Related]
45. Serum studies of leucocyte elastase in acute and chronic lung diseases.
Stockley RA; Ohlsson K
Thorax; 1982 Feb; 37(2):114-7. PubMed ID: 6919307
[TBL] [Abstract][Full Text] [Related]
46. Respiratory dysfunction after cardiac surgery: effects of avoiding cardiopulmonary bypass and the use of bilateral internal mammary arteries.
Taggart DP
Eur J Cardiothorac Surg; 2000 Jul; 18(1):31-7. PubMed ID: 10869938
[TBL] [Abstract][Full Text] [Related]
47. [Effects of ulinastatin on changes of plasma granulocyte elastase, myeloperoxidase and fibronectin during and after open heart surgery].
Mitsuhata H; Enzan K; Hasegawa J; Matsumoto S; Yabe M; Matsumoto J
Masui; 1990 Sep; 39(9):1164-71. PubMed ID: 2174085
[TBL] [Abstract][Full Text] [Related]
48. The effect of leucodepletion on leucocyte activation, pulmonary inflammation and respiratory index in surgery for coronary revascularisation: a prospective randomised study.
Alexiou C; Tang AA; Sheppard SV; Smith DC; Gibbs R; Livesey SA; Monro JL; Haw MP
Eur J Cardiothorac Surg; 2004 Aug; 26(2):294-300. PubMed ID: 15296886
[TBL] [Abstract][Full Text] [Related]
49. Renal function after cardiopulmonary bypass surgery in patients with impaired renal function. A randomized study of the effect of nifedipine.
Witczak BJ; Hartmann A; Geiran OR; Bugge JF
Eur J Anaesthesiol; 2008 Apr; 25(4):319-25. PubMed ID: 18182121
[TBL] [Abstract][Full Text] [Related]
50. The effects of cardiopulmonary bypass temperature on inflammatory response following cardiopulmonary bypass.
Birdi I; Caputo M; Underwood M; Bryan AJ; Angelini GD
Eur J Cardiothorac Surg; 1999 Nov; 16(5):540-5. PubMed ID: 10609905
[TBL] [Abstract][Full Text] [Related]
51. Granulocyte superoxide anion and elastase release during cardiopulmonary bypass.
Haga Y; Hatori N; Yoshizu H; Okuda E; Uriuda Y; Tanaka S
Artif Organs; 1993 Oct; 17(10):837-42. PubMed ID: 8274101
[TBL] [Abstract][Full Text] [Related]
52. Plasma leucocyte elastase concentrations in smokers.
Hind CR; Joyce H; Tennent GA; Pepys MB; Pride NB
J Clin Pathol; 1991 Mar; 44(3):232-5. PubMed ID: 2013624
[TBL] [Abstract][Full Text] [Related]
53. Assessing the depth of isoflurane anaesthesia during cardiopulmonary bypass.
Ng KT; Alston RP; Just G; McKenzie C
Perfusion; 2018 Mar; 33(2):148-155. PubMed ID: 28985693
[TBL] [Abstract][Full Text] [Related]
54. Cardiopulmonary bypass circuit treated with surface-modifying additives: a clinical evaluation of blood compatibility.
Gu YJ; Boonstra PW; Rijnsburger AA; Haan J; van Oeveren W
Ann Thorac Surg; 1998 May; 65(5):1342-7. PubMed ID: 9594864
[TBL] [Abstract][Full Text] [Related]
55. The role of different types of corticosteroids on the inflammatory mediators in cardiopulmonary bypass.
Jansen NJ; van Oeveren W; van Vliet M; Stoutenbeek CP; Eysman L; Wildevuur CR
Eur J Cardiothorac Surg; 1991; 5(4):211-7. PubMed ID: 1711873
[TBL] [Abstract][Full Text] [Related]
56. Effect of cardiopulmonary bypass on leukocyte activation: changes in membrane-bound elastase on neutrophils.
Tang M; Gu YJ; Wang WJ; Xu YP; Chen CZ
Perfusion; 2004 Mar; 19(2):93-9. PubMed ID: 15162923
[TBL] [Abstract][Full Text] [Related]
57. Neutrophil adhesion molecule expression during cardiopulmonary bypass with bubble and membrane oxygenators.
Gillinov AM; Bator JM; Zehr KJ; Redmond JM; Burch RM; Ko C; Winkelstein JA; Stuart RS; Baumgartner WA; Cameron DE
Ann Thorac Surg; 1993 Oct; 56(4):847-53. PubMed ID: 8105757
[TBL] [Abstract][Full Text] [Related]
58. An alternative pathway for fibrinolysis is activated in patients who have undergone cardiopulmonary bypass surgery and major abdominal surgery.
Gando S; Kameue T; Sawamura A; Hayakawa M; Hoshino H; Kubota N
Thromb Res; 2007; 120(1):87-93. PubMed ID: 17023030
[TBL] [Abstract][Full Text] [Related]
59. [Influence of cardiopulmonary bypass on biological response].
Furunaga A; Tsuboi H; Sasaki J; Itoh H; Mikamo A; Okada H; Suzuki K; Gohra H; Hamano K; Katoh T
Kyobu Geka; 1995 Dec; 48(13):1085-7. PubMed ID: 8815250
[TBL] [Abstract][Full Text] [Related]
60. Stimulated elastase release from human leukocytes: influence of anti-asthmatic, anti-inflammatory and calcium antagonist drugs in vitro.
Werner U; Seitz O; Szelenyi I
Agents Actions; 1993; 38 Spec No():C112-4. PubMed ID: 8100381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
